4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazole-2-thiol

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazole-2-thiol
• 英文别名: 4,5-bis(4-chlorophenyl)imidazolidine-2-thione
• 化学式: C₁₅H₁₂Cl₂N₂S
• 分子量: 323.246
• InChiKey: UNATXUHBZRMUKC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  56.2
• 氢给体数：
  2
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazole-2-thiol 在 吡啶 、 氢氧化钾 作用下， 以 乙醇 为溶剂， 反应 10.0h， 生成 3-[4,5-Bis-(4-chloro-phenyl)-2-methylsulfanyl-4,5-dihydro-imidazol-1-yl]-propionitrile
  参考文献：
  名称：

  Sharaf, Mohie A. F.; Ezat, El-Emem H. M.; Hammouda, Hamdy A. A., Journal of Chemical Research, Miniprint, 1996, # 7, p. 1817 - 1830

  摘要：

  DOI：
• 作为产物：
  描述：

  meso-1,2-二(4-氯苯基)乙二胺 、 二硫化碳 生成 4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazole-2-thiol
  参考文献：
  名称：

  CHERKOFSKY, S. C.

  摘要：

  DOI：

文献信息

• Heterocyclic compounds as P2X7 ion channel blockers
  申请人：Shum Patrick

  公开号：US20050026916A1

  公开（公告）日：2005-02-03

  The present invention relates to a novel series of 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives of the formula II: wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , X and Y are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are P2X7 ion channel blockers and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases having an inflammatory component, including inflammatory bowel disease, rheumatoid arthritis and disease conditions associated with the central nervous system, such as stroke, Alzheimer's disease, etc.

  本发明涉及一种新的4,5-二苯基-2-氨基-4,5-二氢咪唑衍生物系列，其化学式为II： 其中R、R1、R2、R3、R4、R5、X和Y如本文所定义。本发明还涉及制备这些化合物的方法。本发明的化合物是P2X7离子通道阻断剂，因此在作为药用剂方面具有用途，特别是在治疗和/或预防具有炎症成分的各种疾病方面，包括炎症性肠病、类风湿关节炎以及与中枢神经系统相关的疾病状况，如中风、阿尔茨海默病等。
• 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions
  申请人：Ciba-Geigy Corporation

  公开号：US04308277A1

  公开（公告）日：1981-12-29

  Compounds of the formula ##STR1## in which R.sub.1 and R.sub.2 independently of one another are substituted or unsubstituted aryl or hetero-aryl groups, R.sub.3 is hydrogen or lower alkyl and R.sub.4 is a substituted or unsubstituted aliphatic hydrocarbon radical, and their pharmaceutically usable salts. These compounds possess immunoregulatory, antithrombotic and antiinflammatory properties and can be used as active ingredients in medicaments. They are prepared, for example, by reacting compounds of the formulae ##STR2## in which one of the radicals X and Y is mercapto, which can be in the form of a salt, and the other is a radical replaceable by etherified mercapto, with one another.

  公式为##STR1##的化合物，其中R.sub.1和R.sub.2分别是取代或未取代的芳基或杂环芳基，R.sub.3是氢或低碳烷基，R.sub.4是取代或未取代的脂肪烃基，以及它们的药用盐。这些化合物具有免疫调节、抗血栓和抗炎性能，并可用作药物的活性成分。例如，它们可通过将公式为##STR2##的化合物进行反应制备，其中X和Y中的一个基团是巯基，可以是盐的形式，另一个是可由醚化巯基取代的基团。
• Antiinflammatory 2-substituted-thio-4,5-dihydro-4,5-diaryl-1H-imidazoles
  申请人：E. I. Du Pont de Nemours & Company

  公开号：US04379159A1

  公开（公告）日：1983-04-05

  Antiinflammatory 2-substituted-thio-4,5-dihydro-4,5-diaryl-1H-imidazoles, such as 4,5-bis(4-chlorophenyl)-4,5-dihydro-2-(2,2,2-trifluoroethylthio)-1H-imidaz ole hydrochloride, useful for treatment of arthritis and related diseases.

  抗炎2-取代硫-4,5-二氢-4,5-二芳基-1H-咪唑类，例如4,5-双(4-氯苯基)-4,5-二氢-2-(2,2,2-三氟乙基硫基)-1H-咪唑盐酸盐，可用于治疗关节炎和相关疾病。
• HETEROCYCLIC COMPOUNDS AS P2X7 ION CHANNEL BLOCKERS
  申请人：SHUM Patrick

  公开号：US20080132550A1

  公开（公告）日：2008-06-05

  The present invention relates to a novel series of 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives of the formula II: wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , X and Y are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are P2X7 ion channel blockers and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases having an inflammatory component, including inflammatory bowel disease, rheumatoid arthritis and disease conditions associated with the central nervous system, such as stroke, Alzheimer's disease, etc.

  本发明涉及一种新的4,5-二苯基-2-氨基-4,5-二氢咪唑衍生物系列，其化学式为II：其中R、R1、R2、R3、R4、R5、X和Y如本文所定义。本发明还涉及制备这些化合物的方法。本发明的化合物是P2X7离子通道阻滞剂，因此在治疗和/或预防具有炎症成分的多种疾病方面，包括炎症性肠病、类风湿性关节炎以及与中枢神经系统相关的疾病状态，如中风、阿尔茨海默病等方面，具有药物学上的用途。
• Imidazothiazole derivatives
  申请人：Kawato Haruko

  公开号：US20090312310A1

  公开（公告）日：2009-12-17

  There is provided a novel compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. The present invention provides an imidazothiazole derivative represented by the following formula (1) having various substituents that inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity: wherein R 1 , R 2 , R 3 , R 4 , and R 5 in the formula (1) each has the same meaning as defined in the specification.

  提供了一种新的化合物，它抑制小鼠双分子分钟2（Mdm2）蛋白与p53蛋白之间的相互作用，并展现出抗肿瘤活性。本发明提供了一种咪唑噻唑衍生物，其表示为以下公式（1），具有各种取代基，可抑制Mdm2蛋白与p53蛋白之间的相互作用并展现出抗肿瘤活性：其中，公式（1）中的R1、R2、R3、R4和R5每个都具有规范中定义的相同含义。